148 related articles for article (PubMed ID: 22902676)
21. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
[TBL] [Abstract][Full Text] [Related]
22. Implementation of newborn hepatitis B vaccination--worldwide, 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1249-52. PubMed ID: 19023261
[TBL] [Abstract][Full Text] [Related]
23. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis.
Broughton EI
J Public Health (Oxf); 2007 Dec; 29(4):441-8. PubMed ID: 17875589
[TBL] [Abstract][Full Text] [Related]
24. Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis.
Devine A; Harvey R; Min AM; Gilder MET; Paw MK; Kang J; Watts I; Hanboonkunupakarn B; Nosten F; McGready R
BMC Infect Dis; 2017 Aug; 17(1):552. PubMed ID: 28793866
[TBL] [Abstract][Full Text] [Related]
25. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
Kim SY; Billah K; Lieu TA; Weinstein MC
Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
[TBL] [Abstract][Full Text] [Related]
26. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries.
Atherly D; Dreibelbis R; Parashar UD; Levin C; Wecker J; Rheingans RD
J Infect Dis; 2009 Nov; 200 Suppl 1():S28-38. PubMed ID: 19817610
[TBL] [Abstract][Full Text] [Related]
27. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.
Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P
Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220
[TBL] [Abstract][Full Text] [Related]
28. The doses of 10 μg should replace the doses of 5 μg in newborn hepatitis B vaccination in China: A cost-effectiveness analysis.
Yin J; Ji Z; Liang P; Wu Q; Cui F; Wang F; Liang X; Zhuang G
Vaccine; 2015 Jul; 33(31):3731-8. PubMed ID: 26057138
[TBL] [Abstract][Full Text] [Related]
29. [Abstract efficacy of combined vaccine for the prevention of HBV transmission in highly viremic HBeAg+ mothers and the HBV markers' dynamic change of babies in follow-up].
Jiang HX; Han GR; Wang CM; Yue X; Wang GJ
Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):818-22. PubMed ID: 22433302
[TBL] [Abstract][Full Text] [Related]
30. Mathematical models of cervical cancer prevention in the Asia Pacific region.
Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers.
Doherty R; Garland S; Wright M; Bulotsky M; Liss C; Lakkis H; Nikas A; Straus W
Pediatr Infect Dis J; 2009 Sep; 28(9):777-81. PubMed ID: 19636283
[TBL] [Abstract][Full Text] [Related]
32. Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves.
Kim SY; Salomon JA; Goldie SJ
Bull World Health Organ; 2007 Nov; 85(11):833-42. PubMed ID: 18038073
[TBL] [Abstract][Full Text] [Related]
33. [Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province].
Zeng YB; Luo ML; He HQ; Deng X; Xie SY; Fang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):706-712. PubMed ID: 31288342
[No Abstract] [Full Text] [Related]
34. Entecavir for the treatment of chronic hepatitis B infection.
Shepherd J; Gospodarevskaya E; Frampton G; Cooper K
Health Technol Assess; 2009 Oct; 13 Suppl 3():31-6. PubMed ID: 19846026
[TBL] [Abstract][Full Text] [Related]
35. Progress in newborn hepatitis B vaccination by birth year cohorts-1998-2007, USA.
Zhao Z; Murphy TV; Jacques-Carroll L
Vaccine; 2011 Dec; 30(1):14-20. PubMed ID: 22063390
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana.
Abbott C; Tiede B; Armah G; Mahmoud A
Vaccine; 2012 Mar; 30(15):2582-7. PubMed ID: 22321664
[TBL] [Abstract][Full Text] [Related]
37. The cost effectiveness of hepatitis immunization for US college students.
Jacobs RJ; Saab S; Meyerhoff AS
J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
[TBL] [Abstract][Full Text] [Related]
38. Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008-2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():768-71. PubMed ID: 23013723
[TBL] [Abstract][Full Text] [Related]
39. Pertussis vaccination strategies for neonates--an exploratory cost-effectiveness analysis.
Scuffham PA; McIntyre PB
Vaccine; 2004 Jul; 22(21-22):2953-64. PubMed ID: 15246632
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of couple-based immunization strategy to prevent mother-to-child transmission of hepatitis B virus in China: A decision-analytic Markov model.
Jing W; Liu J; Wu Y; Ma Q; Liu M
EClinicalMedicine; 2020 Feb; 19():100264. PubMed ID: 32055793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
